CytomX Therapeutics, Inc. (CTMX) News
Latest headlines that mention CTMX, newest first · each headline opens the original publisher
- Last price
- $2.06
- Day change
- +9.57%
- Next earnings
- —
CTMX headlines
last 30 daysLower diarrhea rates emerge, but toxicity control remains the key test.
Also mentioned with CTMX
30dHeadlines that tag both tickers
CTMX news alerts
Get an alert by email or push when a new headline mentions CTMX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.